Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beate Gleissner

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Expert Review of Molecular Diagnostics|June 5, 2003
Molecular genetic events in adult acute lymphoblastic leukemiaBeate Gleissner, Eckhard Thiel
The Lancet. Neurology|April 25, 2006
Neoplastic meningitisBeate Gleissner, Marc Charles Chamberlain
Clinical Lymphoma & Myeloma|March 8, 2008
Aspects of chemotherapy schedules in young and elderly patients with aggressive lymphomaCarsten Zwick, Beate Gleissner, Michael Pfreundschuh
Onkologie|December 8, 2007
Gemtuzumab ozogamicin (mylotarg) for the treatment of acute myeloid leukemia--ongoing trialsBeate Gleissner, Richard Schlenk, Martin Bornhäuser, et al.
The Journal of Steroid Biochemistry and Molecular Biology|March 9, 2010
Notch- and vitamin D signaling in 1,25(OH)2D3-resistant glioblastoma multiforme (GBM) cell linesSandra Reichrath, Cornelia S L Müller, Beate Gleissner, et al.
Blood|August 27, 2005
CD10- pre-B acute lymphoblastic leukemia (ALL) is a distinct high-risk subgroup of adult ALL associated with a high frequency of MLL aberrations: results of the German Multicenter Trials for Adult ALL (GMALL)Beate Gleissner, Nicola Goekbuget, Harald Rieder, et al.
Blood|February 28, 2002
Leading prognostic relevance of the BCR-ABL translocation in adult acute B-lineage lymphoblastic leukemia: a prospective study of the German Multicenter Trial Group and confirmed polymerase chain reaction analysisBeate Gleissner, Nicola Gökbuget, Claus R Bartram, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Expert Review of Molecular Diagnostics|June 5, 2003
Molecular genetic events in adult acute lymphoblastic leukemiaBeate Gleissner, Eckhard Thiel
The Lancet. Neurology|April 25, 2006
Neoplastic meningitisBeate Gleissner, Marc Charles Chamberlain
Clinical Lymphoma & Myeloma|March 8, 2008
Aspects of chemotherapy schedules in young and elderly patients with aggressive lymphomaCarsten Zwick, Beate Gleissner, Michael Pfreundschuh
Onkologie|December 8, 2007
Gemtuzumab ozogamicin (mylotarg) for the treatment of acute myeloid leukemia--ongoing trialsBeate Gleissner, Richard Schlenk, Martin Bornhäuser, et al.
The Journal of Steroid Biochemistry and Molecular Biology|March 9, 2010
Notch- and vitamin D signaling in 1,25(OH)2D3-resistant glioblastoma multiforme (GBM) cell linesSandra Reichrath, Cornelia S L Müller, Beate Gleissner, et al.
Blood|August 27, 2005
CD10- pre-B acute lymphoblastic leukemia (ALL) is a distinct high-risk subgroup of adult ALL associated with a high frequency of MLL aberrations: results of the German Multicenter Trials for Adult ALL (GMALL)Beate Gleissner, Nicola Goekbuget, Harald Rieder, et al.
Blood|February 28, 2002
Leading prognostic relevance of the BCR-ABL translocation in adult acute B-lineage lymphoblastic leukemia: a prospective study of the German Multicenter Trial Group and confirmed polymerase chain reaction analysisBeate Gleissner, Nicola Gökbuget, Claus R Bartram, et al.
Pageof 1